Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Change in Accured Expenses (2020 - 2026)

Maxcyte has reported Change in Accured Expenses over the past 6 years, most recently at -$383000.0 for Q4 2025.

  • Quarterly Change in Accured Expenses rose 17.28% to -$383000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.7 million through Dec 2025, down 97.61% year-over-year, with the annual reading at -$3.7 million for FY2025, 97.61% down from the prior year.
  • Change in Accured Expenses was -$383000.0 for Q4 2025 at Maxcyte, up from -$3.3 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.6 million in Q3 2023 and troughed at -$3.3 million in Q3 2025.
  • The 5-year median for Change in Accured Expenses is -$4000.0 (2024), against an average of -$77725.0.
  • The largest YoY upside for Change in Accured Expenses was 136233.33% in 2023 against a maximum downside of 341.32% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $357850.0 in 2021, then skyrocketed by 172.91% to $976600.0 in 2022, then skyrocketed by 77.35% to $1.7 million in 2023, then tumbled by 126.73% to -$463000.0 in 2024, then increased by 17.28% to -$383000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Change in Accured Expenses are -$383000.0 (Q4 2025), -$3.3 million (Q3 2025), and -$22000.0 (Q2 2025).